Valuation: CellaVision AB

Market Cap 405Cr 41Cr 36Cr 34Cr 30Cr 57Cr 3.87TCr 58Cr 160.34Cr 2.03TCr 153.11Cr 149.85Cr 6.4TCr P/E 2026 *
29.2x
P/E 2027 * 22.6x
Enterprise Value 386.05Cr 39Cr 35Cr 32Cr 29Cr 54Cr 3.69TCr 55Cr 152.84Cr 1.93TCr 145.94Cr 142.84Cr 6.1TCr EV / Sales 2026 *
4.94x
EV / Sales 2027 * 4.35x
Free-Float
81.06%
Yield 2026 *
1.62%
Yield 2027 * 1.9%
1 day-0.12%
1 week+0.83%
Current month-1.96%
1 month+1.07%
3 months+22.16%
6 months+10.84%
Current year+8.02%
1 week 162.2
Extreme 162.2
170.8
1 month 160.6
Extreme 160.6
180.6
Current year 117.6
Extreme 117.6
180.6
1 year 117.6
Extreme 117.6
191.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
448
10 years 75.25
Extreme 75.25
503.5
Manager TitleAgeSince
Chief Executive Officer - 05/06/2026
Director of Finance/CFO 46 02/09/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 04/05/2018
Chairman 64 29/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
14/09/26 Buy

Chief Executive Officer

8,077 0.0339%
02/09/26 Free 1,00,000 0.4193%
28/04/26 Don

Founder

76,434 0.3205%
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%+0.83%-9.39%+30.62% 41Cr
-0.40%-2.34%+17.82%+45.91% 25TCr
+0.33%+0.64%+3.49%+12.96% 16TCr
+1.90%+6.00%-17.96%+65.92% 16TCr
-0.70%+2.93%-55.38%-8.86% 6.62TCr
+0.15%+4.09%+10.82%+65.55% 5.23TCr
+0.24%+0.99%-15.19%-10.88% 5.22TCr
-1.13%+2.85%+16.39%+28.99% 5.13TCr
-0.47%+0.06%+17.37%+58.29% 4.88TCr
-0.42%+3.83%+27.55%+77.45% 4.46TCr
Average -0.06%+2.12%-0.45%+36.60% 8.84TCr
Weighted average by Cap. +0.14%+1.50%+1.37%+38.41%

Financials

2026 *2027 *
Net sales 78Cr 7.87Cr 7.03Cr 6.49Cr 5.89Cr 11Cr 747.31Cr 11Cr 31Cr 391.54Cr 30Cr 29Cr 1.23TCr 88Cr 8.85Cr 7.91Cr 7.3Cr 6.62Cr 12Cr 840.42Cr 13Cr 35Cr 440.33Cr 33Cr 33Cr 1.39TCr
Net income 14Cr 1.4Cr 1.25Cr 1.15Cr 1.04Cr 1.95Cr 132.66Cr 1.99Cr 5.49Cr 70Cr 5.24Cr 5.13Cr 219.14Cr 18Cr 1.83Cr 1.63Cr 1.51Cr 1.37Cr 2.56Cr 173.47Cr 2.6Cr 7.18Cr 91Cr 6.86Cr 6.71Cr 286.54Cr
Net Debt -19Cr -1.91Cr -1.7Cr -1.57Cr -1.43Cr -2.67Cr -181.21Cr -2.71Cr -7.5Cr -95Cr -7.16Cr -7.01Cr -299.32Cr -23Cr -2.32Cr -2.07Cr -1.91Cr -1.73Cr -3.24Cr -219.93Cr -3.29Cr -9.11Cr -115.23Cr -8.69Cr -8.51Cr -363.29Cr
Projected Income Statement - Annual - CellaVision AB
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
251
Date Price Change Volume
23/26/23 SEK 169.80 -0.12% 27,745
22/26/22 SEK 170.00 +3.03% 24,610
21/26/21 SEK 165.00 +0.73% 40,452
20/26/20 SEK 163.80 -1.33% 26,796
19/26/19 SEK 166.00 -1.43% 16,721
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - CellaVision AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
169.80SEK
Average target price
181.67SEK
Spread / Average Target
+6.99%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CellaVision AB
  1. Stock Market
  2. Stocks
  3. CEVI Stock